Food News and Research

RSS

Pew Health Group applauds Senate's passage of historic bipartisan food safety legislation

Erik D. Olson, director of the Pew Health Group food programs, issued the following statement commending the U.S. Senate for passing food safety legislation (S.510):

1 Dec 2010

Pelosi calls for House passage of child nutrition reauthorization legislation

Speaker Nancy Pelosi, House Education and Labor Committee Chairman George Miller, Congresswoman Rosa DeLauro, Congresswoman Carolyn McCarthy, Congressman Jim McGovern and Senator Blanche Lincoln held a press conference call this afternoon to urge House passage of child nutrition reauthorization legislation, which the Senate has already passed. Below are the Speaker's remarks:

1 Dec 2010

CRN says increased DRI for vitamin D a step in right direction, but still falls short

The Council for Responsible Nutrition (CRN), the dietary supplement industry's leading trade association, today called the National Academy of Sciences Institute of Medicine's (IOM) newly released report on the Dietary Reference Intake (DRI) levels for vitamin D "a modest step in the right direction that fell short of truly capturing the extensive and positive research that has consistently supported the need for people to significantly raise their vitamin D levels."

1 Dec 2010

OraSure supports rapid HIV testing initiatives to recognize World AIDS Day

OraSure Technologies, Inc., the market leader in oral fluid diagnostics, today announced its support of more than 150 rapid HIV testing initiatives taking place in more than 25 states in the U.S. and numerous countries globally, in recognition of World AIDS Day, commemorated annually on December 1st.

1 Dec 2010

New experimental device could offer effective treatment option for people with swallowing disorders

In what might be one of the world's first medicinal body piercings, UC Davis Health System surgeons announced today that they have successfully implanted an experimental device in the throat of a man that will enable him to manually control his ability to swallow.

1 Dec 2010

CRN issues statement on passage of FDA Food Safety Modernization Act

"CRN is pleased that the Senate today passed S. 510, FDA Food Safety Modernization Act (FDAFSMA). CRN and its member companies support this bill because of the added enforcement tools it would provide to FDA and the extra protections it would provide for consumers.

1 Dec 2010

Odors in womb sensitize fetus to smells, alters brain development

A major new study shows that a pregnant mother's diet not only sensitizes the fetus to those smells and flavors, but physically changes the brain directly impacting what the infant eats and drinks in the future.

1 Dec 2010

Black rice may help soothe inflammation: Research

The latest episode in the American Chemical Society's (ACS) award-winning podcast series, "Global Challenges/Chemistry Solutions," focuses on the discovery that black rice a little-known variety of the grain that is the staple food for one-third of the world's population may help soothe the inflammation involved in allergies, asthma and other diseases.

1 Dec 2010

Research could lead to new drug treatment for metabolic diseases

A team of Harvard School of Public Health (HSPH) scientists report finding a molecular "switch" that can "turn off" some cellular processes that are protective against aging and metabolic diseases. While more research is needed, the findings may open doors for new drug treatments to halt or slow development of metabolic diseases like type 2 diabetes or heart disease. The research findings appear in the December 1, 2010 issue of Cell Metabolism.

1 Dec 2010

High levels of variability, inconsistencies found in children's medication labeling and measuring devices

An examination of 200 of the top-selling cough/cold, allergy, analgesic and gastrointestinal over-the-counter liquid medications for children finds that there have been high levels of variability and inconsistencies regarding medication labeling and measuring devices, according to a study that will appear in the December 15 issue of JAMA. The study is being released early online because of its public health importance.

1 Dec 2010

Data on UCB’s anti-epileptic drugs to be presented at AES annual meeting

New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.

1 Dec 2010

Rush University enrolls first U.S. patient in international clinical trial for melanoma

Rush University Medical Center has just enrolled the first U.S. patient in an international clinical trial testing a novel drug to treat certain kinds of melanoma, a deadly skin cancer that in its advanced stages currently has few effective treatments.

1 Dec 2010

African agriculture fund designates $135M to expand food production

The African Agriculture Fund (AAF) announced Monday that it has designated $135 million for expanded food production, agricultural processing and distribution, especially for small holder farms, PANA/Afrique en ligne reports.

1 Dec 2010

Elorac's naloxone lotion receives FDA Orphan Drug Designation for pruritus associated with mycosis fungoides

Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders announced that it has been granted Orphan Drug Designation by the U.S. Food and Drug Administration for its naloxone lotion for the topical treatment of pruritus accompanying cutaneous t-cell lymphoma (CTCL, also known as mycosis fungoides).

1 Dec 2010

Medical records and medical device interests gain attention from big names, congressional delegation

The Hill: "The new lobby shop of former Rep. Billy Tauzin (R-La.) and his son Tom has registered its first client. The San Francisco-based tech company Resilient Networks Systems has hired Tauzin Consultants to help lobby on the deployment of electronic medical records under the healthcare reform law among other issues, according to lobbying disclosure records.

30 Nov 2010

ACT files IND application to initiate Phase I/II study for Dry AMD

Advanced Cell Technology, Inc. announced today that it has filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using human embryonic stem cell (hESC) derived retinal pigment epithelial (RPE) cells to treat patients with Dry Age-Related Macular Degeneration (Dry AMD).

30 Nov 2010

NIA awards Aphios Phase I Fast Track SBIR grant for development of novel AD nanodrug

Aphios® Corporation today announced that it was awarded Phase I of a Fast Track SBIR grant from the National Institute of Aging (NIA), National Institutes of Health (NIH) for Developing a Novel Alzheimer's Disease Nanodrug.

30 Nov 2010

Ikaria initiates enrollment in LUCASSIN Phase III trial for HRS Type 1

Ikaria, Inc. announced that it has enrolled the first patients in its pivotal Phase III trial for LUCASSIN® (terlipressin). The multi-center, randomized, placebo-controlled, double-blind trial is known as the REVERSE Trial.

30 Nov 2010

FDA approves Inspire to begin STAR clinical trial to evaluate UAS therapy for OSA

Inspire Medical Systems, a leading developer of neuro-stimulation therapies for the treatment of obstructive sleep apnea (OSA), announced today that the company has received approval from the U.S. Food and Drug Administration (FDA) to begin its STAR pivotal clinical trial. The STAR trial (Stimulation Therapy for Apnea Reduction), is a multi-center study that will evaluate both the safety and effectiveness of Inspire Upper Airway Stimulation (UAS) therapy in patients with moderate to severe obstructive sleep apnea (OSA).

30 Nov 2010

Zogenix completes enrollment in ZX002 Phase 3 study for moderate to severe pain

Zogenix, Inc. today announced completion of enrollment in its open-label Phase 3 safety study (Study 802) of ZX002. ZX002 is a novel, oral, single-entity, controlled-release formulation of hydrocodone for the treatment of moderate to severe pain in patients requiring around-the-clock opioid therapy for an extended period of time.

30 Nov 2010

Food News and Research

Pew Health Group applauds Senate's passage of historic bipartisan food safety legislation

Pelosi calls for House passage of child nutrition reauthorization legislation

CRN says increased DRI for vitamin D a step in right direction, but still falls short

OraSure supports rapid HIV testing initiatives to recognize World AIDS Day

New experimental device could offer effective treatment option for people with swallowing disorders

CRN issues statement on passage of FDA Food Safety Modernization Act

Odors in womb sensitize fetus to smells, alters brain development

Black rice may help soothe inflammation: Research

Research could lead to new drug treatment for metabolic diseases

High levels of variability, inconsistencies found in children's medication labeling and measuring devices

Data on UCB’s anti-epileptic drugs to be presented at AES annual meeting

Rush University enrolls first U.S. patient in international clinical trial for melanoma

African agriculture fund designates $135M to expand food production

Elorac's naloxone lotion receives FDA Orphan Drug Designation for pruritus associated with mycosis fungoides

Medical records and medical device interests gain attention from big names, congressional delegation

ACT files IND application to initiate Phase I/II study for Dry AMD

NIA awards Aphios Phase I Fast Track SBIR grant for development of novel AD nanodrug

Ikaria initiates enrollment in LUCASSIN Phase III trial for HRS Type 1

FDA approves Inspire to begin STAR clinical trial to evaluate UAS therapy for OSA

Zogenix completes enrollment in ZX002 Phase 3 study for moderate to severe pain

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News